Inventors with similar research interests:
Location History:
- Seehiem-Jugenheim, DE (1985)
- Seeheim-Jungenheim, DE (1988)
- Jugendheim, DE (1990)
- Jugenheim, DE (1990 - 1997)
- Seehein-Jugenheim, DE (2001)
- Darmstadt, DE (1977 - 2002)
- Seeheim, DE (1996 - 2010)
- Seeheim-Jugenheim, DE (1983 - 2011)
Company Filing History:
42 out of 1,248 
19 out of 2,943 
3 out of 100 Years Active: 1977-2011
Areas of Expertise:
Title: Christoph Seyfried: Innovations in Central Nervous System Pharmaceuticals
Introduction
Christoph Seyfried is a prominent inventor based in Seeheim-Jugenheim, Germany, known for his significant contributions to the field of pharmaceuticals, particularly in developing compounds that target the central nervous system. With a remarkable portfolio of 71 patents, Seyfried has made strides in addressing various neurodegenerative diseases and psychotropic disorders.
Latest Patents
Seyfried's latest innovations include two noteworthy patents. The first, pertaining to "Substituted Indoles," describes compounds that exhibit distinctive actions on the central nervous system, particularly focusing on 5HT reuptake inhibition and agonistic or antagonistic properties. These compounds have potential therapeutic applications as antipsychotics, neuroleptics, antidepressants, anxiolytics, and antihypertonics, as well as in the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's.
His second patent involves "Chromenoneindoles," which consist of derivatives that also exhibit significant actions on the central nervous system. These compounds are characterized by high bioavailability and potent 5-HT reuptake inhibition, making them prime candidates for further development into medications that target serotonin-related conditions.
Career Highlights
Seyfried has had a distinguished career working with notable companies in the pharmaceutical sector, including Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent GmbH. His experience in these reputable organizations has not only shaped his expertise but also allowed him to develop impactful innovations in drug discovery and development.
Collaborations
Throughout his career, Christoph Seyfried has collaborated with esteemed colleagues such as Gerd Bartoszyk and Henning Bottcher. Together, they have advanced research and development, leading to the creation of valuable therapeutics aimed at improving mental health and treating neurological disorders.
Conclusion
Christoph Seyfried's extensive body of work and continued innovation in pharmaceuticals is a testament to his dedication to science and improving human health. His patents reflect his ground-breaking research that could pave the way for new treatments in mental health and neurodegenerative diseases, underscoring the crucial role inventors play in advancing medical science.